Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation
NCT01925066 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2019-04-23
Summary
The purpose of this study is to determine whether aerosolized vancomycin is effective in the treatment of methicillin-resistant staphylococcus aureus pneumonia under mechanical ventilation.
Conditions
- Pneumonia, Staphylococcal
- Methicillin-Resistant Staphylococcus Aureus
Interventions
- DRUG
Sponsors & Collaborators
-
Seoul National University Bundang Hospital
collaborator OTHER -
Seoul National University Hospital
lead OTHER
Principal Investigators
-
Jae-Joon Yim, MD · Seoul National University Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Efficacy Study of Colistimethate Sodium Inhalation in Patients With Ventilator-associated Pneumonia
NCT01975350 ·Status: TERMINATED
-
Evaluation of Vancomycin Treatment of Infections Due to Staphylococcus Aureus
NCT00862862 ·Status: TERMINATED
-
Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia
NCT00786305 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care
NCT00167986 ·Status: COMPLETED
-
Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin
NCT01561469 ·Status: COMPLETED
-
Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia
NCT01975662 ·Status: TERMINATED ·Phase: PHASE2
-
" a Randomized Pilot Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation (ECMO-VA)."
NCT06602557 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effectiveness of Vancomycin Loading Therapy
NCT01623817 ·Status: COMPLETED ·Phase: NA
-
Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics
NCT01537666 ·Status: COMPLETED ·Phase: PHASE1
-
Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
NCT03816956 ·Status: COMPLETED ·Phase: PHASE3
-
Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates
NCT02806141 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Aerosolised Colistin in Ventilator Associated Pneumonia
NCT02683603 ·Status: COMPLETED ·Phase: PHASE4
-
Vancomycin De-escalation Therapy in Patients With Pneumonia
NCT03586362 ·Status: UNKNOWN
-
Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus
NCT00175370 ·Status: COMPLETED ·Phase: NA
-
Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin
NCT06272994 ·Status: COMPLETED ·Phase: NA
-
Vancomycin Dosage Adjustment for MRSA Infections
NCT03412500 ·Status: UNKNOWN ·Phase: PHASE4
-
Colistin Methanesulfonate Sodium Inhalation for Prophylaxis of Ventilator-Associated Pneumonia (CIVAP): A Prospective, Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial
NCT06834971 ·Status: RECRUITING ·Phase: NA
-
The Most Appropriate Parameter Correlates With Clinical Effectiveness of Vancomycin: Trough Drug Concentration or Area Under Curve (AUC)/Minimum Inhibitory Concentration (MIC)?
NCT01995760 ·Status: COMPLETED
-
Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model
NCT06161870 ·Status: RECRUITING ·Phase: PHASE4
-
Comparison of Epithelial Lining Fluid and Blood Pharmacokinetics and Pharmacodynamics of Intravenous and Intravenous Plus Nebulized Polymyxin B in Multidrug Resistant Bacteria Ventilator-associated Pneumonia Patients
NCT06076603 ·Status: RECRUITING
-
Therapeutic Monitoring of Vancomycin in Critical Ill Patients: a Registry
NCT02896218 ·Status: UNKNOWN
-
Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.
NCT00150852 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
NCT00124020 ·Status: COMPLETED ·Phase: PHASE3
-
Vancomycin Dosage Strategy Based on a Trough Concentration Model
NCT04088305 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia
NCT01819935 ·Status: COMPLETED